A team led by scientists from Van Andel Institute and Max Planck Institute of Immunobiology and Epigenetics has made an important discovery regarding the treatment of Type 1 and Type 2 diabetes. The team has revealed two distinct subtypes of insulin-producing beta cells, which can be vital in understanding and treating both forms of diabetes.…
Read MoreBeef, chicken, and pork are some of the most popular protein sources in our daily diets. Not only are they delicious and a great source of essential nutrients, but recent research has found that they are also unique sources of antioxidants. People need antioxidants to help combat oxidative stress in the body. Oxidative stress is…
Read MoreIn recent years, AI technology has developed to incredible heights and its potential applications in the sciences have been exponentially increasing. From self-driving cars to unlocking the mysteries of dark matter, artificial intelligence has become a powerful tool of unprecedented breadth. Now, scientists are exploring another possible use for AI: generating original proteins from scratch…
Read MoreNews Claritas Genomics to Present 4 Posters and a Talk ‘Phenotype First: The Power of a Tailored Exome’ at ACMG Annual Clinical Genetics Meeting CAMBRIDGE, Mass., March 24, 2015 /PRNewswire-USNewswire/ — Claritas Genomics will present data on the quality of parallel multi-technology sequencing, a comparison of the company’s phenotypically driven Pediatric Neurology Exome Assay to whole exome…
Read MoreCAMBRIDGE, Mass., March 24, 2015 /PRNewswire-USNewswire/ — Claritas Genomics will present data on the quality of parallel multi-technology sequencing, a comparison of the company’s phenotypically driven Pediatric Neurology Exome Assay to whole exome and panel-based approaches, three-part reports for rapid results reporting, and the clinical utility of the Neurology Exome’s tailored approach compared to other tests currently…
Read MoreJuly 23, 2014: Dr. Yiping Shen, a Clinical Genetics Medical Director at Claritas Genomics presented a webinar sponsored by Agilent Technologies on Claritas’s ClariView Array, a microarray designed for patients with autism, developmental delay, or intellectual disability. More information about the webinar can be found by visiting Agilent’s website. Visit the ClariView Array webpage to…
Read MoreJanuary 8, 2013 Spinoff venture will develop genomic sequencing solutions utilizing Ion Torrent technology for clinical applications SAN FRANCISCO, Jan. 8, 2013 /PRNewswire-USNewswire/ — Boston Children’s Hospital has partnered with Life Technologies Corporation(NASDAQ: LIFE) to launch Claritas Genomics, a new company formed to develop next-generation, genetic and genomics-based diagnostic testing solutions. The venture combines advanced instrumentation, software and bioinformatics capabilities with sophisticated clinical…
Read MoreClaritas Genomics is pleased to announce that it is now a Certified Service Provider in the Life Technologies Ion AmpliSeq™ Exome network. Through this program, Claritas Genomics offers Ion AmpliSeq™ Exome Sequencing Research Services using the Ion Proton System. Researchers will receive high-quality sequencing data and will have access to the Ion Reporter™ software for annotation and further analysis. Base…
Read MoreFOR IMMEDIATE RELEASE Nov 12, 2013 Pediatric hospitals to share data and genomic testing infrastructure for the benefit of patients Cambridge, Nov 12— Cincinnati Children’s Medical Center has partnered with Claritas Genomics, a company formed by Boston Children’s Hospital and Life Technologies Corporation (NASDAQ: LIFE), to provide genomics-based diagnostics for pediatric patients. Cincinnati Children’s will work…
Read MoreOn May 1, 2014 at the Executive War College in New Orleans, Patrice spoke about Claritas Genomics’ evolution into a national genetic testing company. The title of her presentation was “Claritas Genomics: Transforming a Hospital-Based Molecular Lab into a Next-Generation Pediatric Diagnostic Company.”
Read More